Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains?

被引:23
|
作者
Kutluk, Gunsel [1 ]
Tutar, Engin [1 ]
Bayrak, Aykut [1 ]
Volkan, Burcu [1 ]
Akyon, Yakut [3 ]
Celikel, Cigdem [2 ]
Ertem, Deniz [1 ]
机构
[1] Marmara Univ Sch Med, Div Pediat Gastroenterol Hepatol & Nutr, TR-34854 Istanbul, Turkey
[2] Marmara Univ Sch Med, Dept Pathol, TR-34854 Istanbul, Turkey
[3] Hacettepe Univ Sch Med, Dept Microbiol, Ankara, Turkey
关键词
antibiotic resistance; children; Helicobacter pylori; sequential; standard; treatment; ANTIBIOTIC-RESISTANCE; RANDOMIZED-TRIAL; CONSENSUS REPORT; INFECTION; METAANALYSIS; MANAGEMENT; GENOTYPES; REGIMEN; SPECIMENS; TRENDS;
D O I
10.1097/MEG.0000000000000190
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective There has been a marked decrease in the eradication rates of Helicobacter pylori infection with standard triple therapy worldwide. Hence, sequential therapy has gained attention as a promising treatment during the last few years. This study was carried out to compare the efficacy of sequential versus standard triple therapy in the context of clarithromycin (CLA) resistance. Materials and methods In this study, children between 3 and 18 years of age, who had documented H. pylori infection, were randomized to receive either standard triple or sequential therapy. H. pylori eradication was ascertained using the C-13-urea breath test 4-6 weeks after the completion of the treatment. Real-time PCR was performed on gastric biopsy samples for assessment of CLA resistance. Results In all, 148 children (median age: 12.18 +/- 3.51 years) were recruited randomly into the study. The intention-to-treat eradication rates were 50% (37/74) for the sequential treatment group and 52.7% (39/74) for the standard triple treatment group (P = 0.87). A total of 136 children completed the study. The per-protocol eradication rates were 56% (37/66) and 55.7% (39/70) for sequential and standard triple therapy groups, respectively. CLA resistance was assessed and 113 children were included in the final analysis. Of 113 participants, 53 were in the sequential treatment group and 60 were in the standard triple treatment group. The success rates of the respective therapies (29/53 = 54.7% in sequential, 33/60 = 55% in standard therapy) were similar (P = 0.98). CLA resistance was detected in 29 (25.7%) of the patients. Eradication rates with sequential therapy in CLA susceptible and resistant cases were 60.5% (23/38) and 40% (6/15), respectively (P = 0.23). The corresponding figures for the standard triple treatment group were 63% (29/46) and 28.6% (4/14) (P = 0.033). Although a higher eradication rate was observed in CLA-resistant cases with sequential therapy, the difference did not reach statistical significance (P = 0.69). Conclusion In this study, standard triple treatment failed to eradicate H. pylori infection in the majority of the children, and sequential therapy offered only a small advantage over standard triple therapy in the eradication of CLA-resistant strains. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:1202 / 1208
页数:7
相关论文
共 50 条
  • [41] Azithromycin based triple therapy versus standard clarithromycin based triple therapy in eradication of Helicobacter pylori infection in Iran: a randomized controlled clinical trial
    Sarkeshikian, Seyed Saeid
    Iranikhah, Abolfazl
    Ghadir, Mohammad Reza
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2013, 24 (01): : 10 - 14
  • [42] Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori
    Sullivan, B
    Coyle, W
    Nemec, R
    Dunteman, T
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (10): : 2536 - 2539
  • [43] The safety of triple therapy with lansoprazole, clarithromycin, and amoxicillin in the eradication of Helicobacter pylori
    Campbell, DR
    Kim, J
    Rose, P
    Stickler, T
    Jennings, D
    GASTROENTEROLOGY, 1997, 112 (04) : A82 - A82
  • [44] Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy
    Osaki, Takako
    Mabe, Katsuhiro
    Zaman, Cynthia
    Yonezawa, Hideo
    Okuda, Masumi
    Amagai, Kenji
    Fujieda, Shinji
    Goto, Mitsuhide
    Shibata, Wataru
    Kato, Mototsugu
    Kamiya, Shigeru
    HELICOBACTER, 2017, 22 (05)
  • [45] Dual versus triple therapy in eradication of Helicobacter pylori
    Ohlin, B
    Cederberg, Å
    Kjellin, T
    Kullman, E
    Melén, K
    von Holstein, CS
    Thoring, M
    HEPATO-GASTROENTEROLOGY, 2002, 49 (43) : 172 - 175
  • [46] Do probiotics improve eradication response to Helicobacter pylori on standard triple or sequential therapy
    Dajani, Asad I.
    Abu Hammour, Adnan M.
    Yang, Ding H.
    Chung, Peter C.
    Nounou, Mohammed A.
    Yuan, KaiTao Y.
    Zakaria, Mohammed A.
    Schi, Hanping S.
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2013, 19 (03): : 113 - 120
  • [47] Efficacy of Lactoferrin with Standard Triple Therapy or Sequential Therapy for Helicobacter pylori Eradication: A Randomized Controlled Trial
    Hablass, Fahmy H.
    Lashen, Sameh A.
    Alsayed, Eman A.
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2021, 32 (09): : 742 - 749
  • [48] Efficacy and safety of sequential therapy versus standard triple therapy in Helicobacter pylori eradication in Kashmir India: A randomized comparative trial
    Javid G.
    Zargar S.A.
    Bhat K.
    Khan B.A.
    Yatoo G.N.
    Gulzar G.M.
    Shah A.H.
    Sodhi J.S.
    Khan M.A.
    Shoukat A.
    Saif R.U.
    Indian Journal of Gastroenterology, 2013, 32 (3) : 190 - 194
  • [49] Effect of sequential versus standard Helicobacter pylori eradication therapy on the associated iron deficiency anemia in children
    Habib, Hamed Said Ali
    Murad, Hussam Aly Sayed
    Amir, Elamir Mahmoud
    Halawa, Taher Fawzy
    INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 (05) : 470 - 473
  • [50] Sequential Therapy Compared with Standard Triple Therapy for Helicobacter Pylori Eradication in Children: A Double-Blind, Randomized, Controlled Trial
    Albrecht, Piotr
    Kotowska, Maria
    Szajewska, Hania
    JOURNAL OF PEDIATRICS, 2011, 159 (01): : 45 - 49